Cosaic secures USD 6 million seed extension to advance yeast-derived ingredient platform

21.04.2026

Swiss food biotech company Cosaic has raised USD 6 million in a seed extension round, reinforcing continued interest in foodtech solutions that combine technical differentiation with a clear path to market. The funding comes at a time when capital has become more selective, particularly in the food and biotech sectors.

VK_Article_Small_400x30040.jpg
Cosaic is developing a new category of food ingredients based on yeast fermentation. Its platform focuses on delivering multiple functionalities, such as creaminess, stability, and texture, within a single ingredient. This approach addresses formulation challenges that have traditionally required several additives, offering manufacturers a more integrated solution.

The latest financing will support three main priorities as the company moves toward market readiness. These include advancing regulatory processes, scaling up production capabilities, and conducting industrial trials with large food and beverage manufacturers.

The round reflects a broader shift in the foodtech sector, where companies are moving beyond one-to-one ingredient replacement strategies. Instead, there is increasing focus on solutions that provide measurable functional value and can be more easily integrated into existing manufacturing processes.

Cosaic’s progress follows a strategic go-to-market partnership with Ingredion, announced in late 2025. The collaboration provided early commercial validation and access to established industry channels. With this foundation and new backing from DMS-Firmenich’s venture arm, the company is accelerating its transition from product development to market entry.

The foodtech company has been supported by Venture Kick and has been ranked among the Top100 Swiss Startups.

Cosaic co-founders Tomas Turner (CEO) and Dimitri Zogg (CTO)

Additional Links